Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04239963 · ClinicalTrials.gov registry record
Behavioral and Electrophysiological Effects of Ketamine in Treatment-Resistant Depression
A clinical trial, sponsored by Mclean Hospital.
- Completed
- Registry status
- 60
- Enrollment target
NCT04239963: Completed study, sponsored by Mclean Hospital.
NCT04239963 is a clinical trial that has completed, run by Mclean Hospital. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04239963 has completed, sponsored by Mclean Hospital.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The overarching goal of the present study is to evaluate the effect of a subanesthetic dose of ketamine 24-hour post-injection on resting state functional connectivity, cognitive control, and reward learning.
Primary Outcome
Relative FRP response is the primary outcome measure for the probabilistic reward task (PRT).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-08-17 |
| Est. Completion | 2024-08-28 |
What the finished NCT04239963 record still lists
NCT04239963 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04239963 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04239963 about?
NCT04239963 is a clinical study titled "Behavioral and Electrophysiological Effects of Ketamine in Treatment-Resistant Depression". The overarching goal of the present study is to evaluate the effect of a subanesthetic dose of ketamine 24-hour post-injection on resting state functional connectivity, cognitive control, and reward learning.
What is the current status of trial NCT04239963?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2020-08-17. Estimated completion is 2024-08-28.
Who is sponsoring clinical trial NCT04239963?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI